Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Expected to Earn FY2024 Earnings of $2.86 Per Share

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Investment analysts at Leerink Partnrs dropped their FY2024 earnings estimates for shares of Walgreens Boots Alliance in a report released on Thursday, June 27th. Leerink Partnrs analyst M. Cherny now anticipates that the pharmacy operator will earn $2.86 per share for the year, down from their prior forecast of $3.19. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $2.94 per share. Leerink Partnrs also issued estimates for Walgreens Boots Alliance’s Q3 2025 earnings at $0.58 EPS.

A number of other analysts have also commented on WBA. Truist Financial dropped their price target on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research note on Friday, June 28th. Bank of America reaffirmed an “underperform” rating and set a $11.00 target price (down previously from $22.00) on shares of Walgreens Boots Alliance in a research note on Friday, June 28th. TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating for the company in a report on Monday. Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Finally, JPMorgan Chase & Co. lowered their target price on Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating for the company in a research note on Monday. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $18.07.

Walgreens Boots Alliance Trading Down 0.1 %

NASDAQ WBA opened at $11.57 on Monday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. Walgreens Boots Alliance has a fifty-two week low of $11.40 and a fifty-two week high of $31.32. The stock has a market cap of $9.99 billion, a P/E ratio of -1.72, a price-to-earnings-growth ratio of 0.82 and a beta of 0.72. The stock has a 50 day simple moving average of $16.36 and a two-hundred day simple moving average of $20.05.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The firm had revenue of $36.40 billion for the quarter, compared to analysts’ expectations of $35.94 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The business’s revenue for the quarter was up 2.8% on a year-over-year basis.

Institutional Investors Weigh In On Walgreens Boots Alliance

Several large investors have recently bought and sold shares of the business. Highlander Capital Management LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter valued at $26,000. Pineridge Advisors LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Venturi Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 981 shares during the period. Rocky Mountain Advisers LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at about $30,000. Finally, Quest Partners LLC bought a new position in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $30,000. 58.59% of the stock is currently owned by institutional investors.

Insider Activity at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 8.64%. The ex-dividend date of this dividend was Monday, May 20th. Walgreens Boots Alliance’s payout ratio is -14.84%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.